JP2016534078A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016534078A5 JP2016534078A5 JP2016525966A JP2016525966A JP2016534078A5 JP 2016534078 A5 JP2016534078 A5 JP 2016534078A5 JP 2016525966 A JP2016525966 A JP 2016525966A JP 2016525966 A JP2016525966 A JP 2016525966A JP 2016534078 A5 JP2016534078 A5 JP 2016534078A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- glycosaminoglycan
- sulfated polysaccharide
- drug according
- polysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 16
- 150000004676 glycans Chemical class 0.000 claims 16
- 229920001282 polysaccharide Polymers 0.000 claims 16
- 239000005017 polysaccharide Substances 0.000 claims 16
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 13
- 229940079593 drug Drugs 0.000 claims 9
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 7
- 229920000669 heparin Polymers 0.000 claims 5
- 229960000633 dextran sulfate Drugs 0.000 claims 4
- 229960002897 heparin Drugs 0.000 claims 4
- 229940043138 pentosan polysulfate Drugs 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 2
- 230000004663 cell proliferation Effects 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 230000010399 physical interaction Effects 0.000 claims 2
- 230000010152 pollination Effects 0.000 claims 2
- 230000019635 sulfation Effects 0.000 claims 2
- 238000005670 sulfation reaction Methods 0.000 claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical group O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 229920000855 Fucoidan Polymers 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229960004969 dalteparin Drugs 0.000 claims 1
- 229960000610 enoxaparin Drugs 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 239000003055 low molecular weight heparin Substances 0.000 claims 1
- 229940127215 low-molecular weight heparin Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229960005062 tinzaparin Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102013111630.2 | 2013-10-22 | ||
| DE102013111630 | 2013-10-22 | ||
| PCT/EP2014/072620 WO2015059177A1 (en) | 2013-10-22 | 2014-10-22 | Sulfated polysaccharides for use in the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016534078A JP2016534078A (ja) | 2016-11-04 |
| JP2016534078A5 true JP2016534078A5 (enExample) | 2017-01-19 |
| JP6444399B2 JP6444399B2 (ja) | 2018-12-26 |
Family
ID=51795625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016525966A Active JP6444399B2 (ja) | 2013-10-22 | 2014-10-22 | 癌の処置に用いるための硫酸化多糖 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10098906B2 (enExample) |
| EP (1) | EP3060223B1 (enExample) |
| JP (1) | JP6444399B2 (enExample) |
| AU (1) | AU2014339000B2 (enExample) |
| CA (1) | CA2926888C (enExample) |
| WO (1) | WO2015059177A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016196256A2 (en) | 2015-06-04 | 2016-12-08 | University Of North Carolina At Greensboro | Non-aromatic difluoro analogues of resorcylic acid lactones |
| US11191743B2 (en) * | 2016-01-11 | 2021-12-07 | Dignity Health | Modulators of zinc activated cation channel |
| CA3072856A1 (en) | 2017-08-23 | 2019-02-28 | Cell Receptor AG | Combination of a mapk/erk pathway inhibitor and a glycosaminoglycan for the treatment of cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5262403A (en) * | 1986-03-10 | 1993-11-16 | Board Of Regents, The University Of Texas System | Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II |
| US7781416B2 (en) * | 2000-01-25 | 2010-08-24 | Sigma-Tau Research Switzerland S.A. | Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| US20060154894A1 (en) * | 2004-09-15 | 2006-07-13 | Massachusetts Institute Of Technology | Biologically active surfaces and methods of their use |
| WO2010096466A2 (en) * | 2009-02-17 | 2010-08-26 | Novelmed Therapeutics, Inc. | Methods and compositions for inhibiting cellular proliferation and surgical adhesion |
| CN102917711A (zh) * | 2010-03-12 | 2013-02-06 | 澳大利亚国立大学 | 硫酸乙酰肝素替代疗法 |
| IT1401253B1 (it) * | 2010-04-23 | 2013-07-18 | Uni Degli Studi Carlo Bo Urbino | Uso del sulodexide per la riduzione delle metalloproteinasi di matrice. |
| TWI520740B (zh) * | 2011-02-02 | 2016-02-11 | 模範健康科技私人企業有限公司 | 利用多硫酸化多醣之骨髓水腫（水腫）的治療 |
| DK2861273T3 (da) * | 2012-06-13 | 2017-11-27 | Exthera Medical Corp | Anvendelse af heparin og kulhydrater til behandling af cancer. |
| EP3131534A4 (en) * | 2014-04-17 | 2017-12-20 | Memorial Sloan Kettering Cancer Center | Fucoidan nanogels and methods of their use and manufacture |
-
2014
- 2014-10-22 JP JP2016525966A patent/JP6444399B2/ja active Active
- 2014-10-22 US US15/031,020 patent/US10098906B2/en active Active
- 2014-10-22 AU AU2014339000A patent/AU2014339000B2/en active Active
- 2014-10-22 EP EP14789548.6A patent/EP3060223B1/en active Active
- 2014-10-22 CA CA2926888A patent/CA2926888C/en active Active
- 2014-10-22 WO PCT/EP2014/072620 patent/WO2015059177A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jiang et al. | Chitosan as a biomaterial: structure, properties, and applications in tissue engineering and drug delivery | |
| Pham et al. | Strategies for the design of orally bioavailable antileishmanial treatments | |
| Pradhan et al. | A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections | |
| Witting et al. | Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers | |
| Vecsernyés et al. | Cyclodextrins, blood–brain barrier, and treatment of neurological diseases | |
| Zaferani et al. | Heparin/heparan sulphate interactions with complement—a possible target for reduction of renal function loss? | |
| JP2014240439A5 (enExample) | ||
| HK1205156A1 (en) | Cyclodextrin-based polymers for therapeutic delivery | |
| BR112015013774A2 (pt) | membrana de hidrogel para prevenção de adesão | |
| JP2012529506A5 (enExample) | ||
| MY198582A (en) | Pentosan polysulfate, pharmaceutical composition, and anticoagulant | |
| JP2016534078A5 (enExample) | ||
| Kalimuthu et al. | Fucoidan, a sulfated polysaccharides from brown algae as therapeutic target for cancer | |
| MX351104B (es) | Nuevos glucosaminoglucanos con baja actividad anticoagulante. | |
| JP2015514705A5 (enExample) | ||
| MX2022003422A (es) | Derivado de heteroarilamidopiridinol y composicion farmaceutica que comprende el mismo como ingrediente activo para prevencion o tratamiento de enfermedad autoinmune. | |
| MX2016005883A (es) | Formulaciones de acido poliinosinico-policitidilico (poli (i:c))para el tratamiento de infecciones del tracto respiratorio superior. | |
| RU2014143008A (ru) | Способ лечения остановки родов | |
| RU2017142710A (ru) | Состав полиинозиновой-полицитидиловой кислоты (поли-(i:с)) на основе горохового крахмала для профилактики и/или лечения инфекций верхних дыхательных путей | |
| JP2011037849A (ja) | 消化性潰瘍及び十二指腸潰瘍の治療及び予防に使用されるヒアルロン酸混合物 | |
| JP2015511664A5 (enExample) | ||
| JP2014504613A5 (enExample) | ||
| WO2014075203A1 (es) | Nanopartículas con polímero biodegradable y biocompatible plga cargadas con el fármaco de uso humano pentoxfilina | |
| CN109983015A (zh) | 6-吡唑-[1,2,4]三唑并[4,3-a]吡啶-3-酰胺类衍生物、其制备方法及其在医药上的应用 | |
| JP2016519143A5 (enExample) |